Western Blot – News and Features

In this interview, we speak to Vikram Devgan at NanoString Technologies to learn more about how added context from spatial biology techniques can provide more detailed insights during tissue analysis.

This article will highlight various analytical techniques employed in biopharmaceutical analysis and explore their use at different stages of the development pipeline.

In this article, Dr. Kenneth Oh discusses how a comprehensive qPCR–western blot–multiplex assay workflow can revolutionize drug discovery approaches.

This article explores the current state of Lyme disease testing and how improvements could be made in the future to improve time to diagnosis.

Gel electrophoresis is a fundamental technique for separating molecules such as DNA, RNA and proteins in laboratories across the biological disciplines. But how does polyacrylamide gel electrophoresis (PAGE) works and what are its applications?

Renowned scientists and engineers from the Massachusetts Institute of Technology (MIT) have developed and tested a capsule-based system for oral delivery of mRNA therapeutics.

Antibodies are immunological proteins that play fundamental roles in host defense against infectious agents such as viruses, bacteria and fungi. Two types of antibodies – polyclonal and monoclonal – provide research scientists with distinct ways to detect or quantify target antigens largely due to differences in specificity and affinity. In this article, we describe polyclonal and monoclonal antibodies in more detail and consider how each type may be used for various applications.

There are many reasons you may need to determine the presence (or absence) and size of a given protein within a sample, potentially against a background of many others. The western blot is one such technique that offers these capabilities. In this article, we discuss what western blots are, how they are performed, what they show us and how they differ to related techniques.

A blood test that quantifies the protein ACE2, the cellular protein which allows entry of the virus into cells, as well as ACE2 fragments, produced as a result of interaction with the virus, could be an effective method for monitoring SARS-CoV-2 infection.

The European Proteomics Infrastructure Consortium providing Access, or EPIC-XS, started in January 2019. It brings together a consortium of world-leading, highly innovative European proteomics facilities with the shared goal of supporting excellent life sciences research in Europe. In this article, Martina O'Flaherty provides an overview of some of the successes of the consortium so far.